Thermo Fisher Scientific Inc. $TMO Shares Purchased by California State Teachers Retirement System

Key Points

• California State Teachers Retirement System dramatically increased its Thermo Fisher Scientific position by acquiring 282.1 million additional shares in the second quarter, bringing its reported stake to 282.7 million shares, or approximately 76.44% of the company.
• Analysts remain broadly bullish, with a consensus “Moderate Buy” rating and an average price target of $619.41. Thermo Fisher also exceeded quarterly earnings and revenue estimates, reporting $6.03 in EPS and $11.99 billion in revenue.
• Thermo Fisher shares opened at $612.75, while insiders sold 73,768 shares worth about $44.1 million over the past three months. The company declared a quarterly dividend of $0.47 per share, representing a 0.3% annualized yield.

California State Teachers Retirement System grew its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 49,331.5% in the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 282,654,735 shares of the medical research company's stock after acquiring an additional 282,082,924 shares during the quarter. California State Teachers Retirement System owned about 76.44% of Thermo Fisher Scientific worth $141,711,778,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Legacy Wealth Managment LLC ID raised its stake in Thermo Fisher Scientific by 78.6% during the 1st quarter. Legacy Wealth Managment LLC ID now owns 50 shares of the medical research company's stock valued at $25,000 after acquiring an additional 22 shares in the last quarter. Kilter Group LLC bought a new position in shares of Thermo Fisher Scientific in the second quarter worth $25,000. Allied Private Wealth LLC acquired a new position in shares of Thermo Fisher Scientific during the second quarter valued at $26,000. High Note Wealth LLC raised its stake in shares of Thermo Fisher Scientific by 170.6% during the fourth quarter. High Note Wealth LLC now owns 46 shares of the medical research company's stock valued at $27,000 after purchasing an additional 29 shares in the last quarter. Finally, JPL Wealth Management LLC acquired a new stake in Thermo Fisher Scientific in the third quarter worth about $28,000. Institutional investors and hedge funds own 89.23% of the company's stock.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. Evercore set a $570.00 target price on shares of Thermo Fisher Scientific in a research note on Monday, July 6th. HSBC upgraded shares of Thermo Fisher Scientific from a "hold" rating to a "strong-buy" rating in a report on Tuesday, September 1st. Wall Street Zen raised Thermo Fisher Scientific from a "hold" rating to a "buy" rating in a report on Saturday, August 1st. Barclays increased their price target on Thermo Fisher Scientific from $625.00 to $650.00 and gave the company an "overweight" rating in a research note on Friday, July 24th. Finally, Jefferies Financial Group reissued a "buy" rating and issued a $630.00 price objective on shares of Thermo Fisher Scientific in a research note on Thursday, July 23rd. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $619.41.

Insiders Place Their Bets

In other news, VP Lisa P. Britt sold 11,440 shares of Thermo Fisher Scientific stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $613.12, for a total value of $7,014,092.80. Following the transaction, the vice president directly owned 14,784 shares of the company's stock, valued at $9,064,366.08. This trade represents a 43.62% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, CAO Joseph R. Holmes sold 420 shares of the business's stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $584.81, for a total transaction of $245,620.20. Following the sale, the chief accounting officer owned 2,966 shares in the company, valued at $1,734,546.46. This represents a 12.40% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 73,768 shares of company stock worth $44,122,820 over the last three months. Company insiders own 0.33% of the company's stock.

Thermo Fisher Scientific Stock Down 0.2%

NYSE TMO opened at $612.75 on Monday. Thermo Fisher Scientific Inc. has a 12 month low of $435.27 and a 12 month high of $647.00. The company has a market capitalization of $226.56 billion, a P/E ratio of 32.96, a PEG ratio of 2.57 and a beta of 0.85. The company's 50 day simple moving average is $570.91 and its 200 day simple moving average is $515.17. The company has a debt-to-equity ratio of 0.74, a current ratio of 1.55 and a quick ratio of 1.18.

Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last posted its quarterly earnings results on Thursday, July 23rd. The medical research company reported $6.03 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.71 by $0.32. Thermo Fisher Scientific had a net margin of 15.04% and a return on equity of 17.09%. The firm had revenue of $11.99 billion for the quarter, compared to analyst estimates of $11.71 billion. During the same quarter in the previous year, the business posted $4.28 earnings per share. The firm's quarterly revenue was up 10.5% compared to the same quarter last year. Thermo Fisher Scientific has set its FY 2026 guidance at 24.930-25.330 EPS. Equities research analysts expect that Thermo Fisher Scientific Inc. will post 25.13 earnings per share for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Tuesday, September 15th will be issued a dividend of $0.47 per share. This represents a $1.88 annualized dividend and a dividend yield of 0.3%. The ex-dividend date of this dividend is Tuesday, September 15th. Thermo Fisher Scientific's dividend payout ratio is currently 10.11%.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific NYSE: TMO is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.